Request for Covid-19 Impact Assessment of this Report
The United States Veterinary Biological Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Veterinary Biological Vaccines market, reaching US$ million by the year 2028. As for the Europe Veterinary Biological Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Veterinary Biological Vaccines players cover Merck, Zoetis, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biological Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Live Attenuated Vaccines
Inactivated Vaccines
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Livestock
Swine
Chicken
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Biological Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Veterinary Biological Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Veterinary Biological Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Veterinary Biological Vaccines Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Others
2.3 Veterinary Biological Vaccines Sales by Type
2.3.1 Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Veterinary Biological Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Veterinary Biological Vaccines Sale Price by Type (2017-2022)
2.4 Veterinary Biological Vaccines Segment by Application
2.4.1 Livestock
2.4.2 Swine
2.4.3 Chicken
2.4.4 Others
2.5 Veterinary Biological Vaccines Sales by Application
2.5.1 Global Veterinary Biological Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Veterinary Biological Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Veterinary Biological Vaccines Sale Price by Application (2017-2022)
3 Global Veterinary Biological Vaccines by Company
3.1 Global Veterinary Biological Vaccines Breakdown Data by Company
3.1.1 Global Veterinary Biological Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Veterinary Biological Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Veterinary Biological Vaccines Revenue by Company (2020-2022)
3.2.2 Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Veterinary Biological Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Biological Vaccines Product Location Distribution
3.4.2 Players Veterinary Biological Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary Biological Vaccines by Geographic Region
4.1 World Historic Veterinary Biological Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Veterinary Biological Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Veterinary Biological Vaccines Annual Revenue by Geographic Region
4.2 World Historic Veterinary Biological Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Veterinary Biological Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Veterinary Biological Vaccines Annual Revenue by Country/Region
4.3 Americas Veterinary Biological Vaccines Sales Growth
4.4 APAC Veterinary Biological Vaccines Sales Growth
4.5 Europe Veterinary Biological Vaccines Sales Growth
4.6 Middle East & Africa Veterinary Biological Vaccines Sales Growth
5 Americas
5.1 Americas Veterinary Biological Vaccines Sales by Country
5.1.1 Americas Veterinary Biological Vaccines Sales by Country (2017-2022)
5.1.2 Americas Veterinary Biological Vaccines Revenue by Country (2017-2022)
5.2 Americas Veterinary Biological Vaccines Sales by Type
5.3 Americas Veterinary Biological Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Biological Vaccines Sales by Region
6.1.1 APAC Veterinary Biological Vaccines Sales by Region (2017-2022)
6.1.2 APAC Veterinary Biological Vaccines Revenue by Region (2017-2022)
6.2 APAC Veterinary Biological Vaccines Sales by Type
6.3 APAC Veterinary Biological Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Biological Vaccines by Country
7.1.1 Europe Veterinary Biological Vaccines Sales by Country (2017-2022)
7.1.2 Europe Veterinary Biological Vaccines Revenue by Country (2017-2022)
7.2 Europe Veterinary Biological Vaccines Sales by Type
7.3 Europe Veterinary Biological Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Biological Vaccines by Country
8.1.1 Middle East & Africa Veterinary Biological Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Veterinary Biological Vaccines Sales by Type
8.3 Middle East & Africa Veterinary Biological Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines
10.3 Manufacturing Process Analysis of Veterinary Biological Vaccines
10.4 Industry Chain Structure of Veterinary Biological Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Biological Vaccines Distributors
11.3 Veterinary Biological Vaccines Customer
12 World Forecast Review for Veterinary Biological Vaccines by Geographic Region
12.1 Global Veterinary Biological Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary Biological Vaccines Forecast by Region (2023-2028)
12.1.2 Global Veterinary Biological Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Biological Vaccines Forecast by Type
12.7 Global Veterinary Biological Vaccines Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Biological Vaccines Product Offered
13.1.3 Merck Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Biological Vaccines Product Offered
13.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Biological Vaccines Product Offered
13.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Biological Vaccines Product Offered
13.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Biological Vaccines Product Offered
13.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Biological Vaccines Product Offered
13.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Yebio
13.7.1 Yebio Company Information
13.7.2 Yebio Veterinary Biological Vaccines Product Offered
13.7.3 Yebio Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Yebio Main Business Overview
13.7.5 Yebio Latest Developments
13.8 DHN
13.8.1 DHN Company Information
13.8.2 DHN Veterinary Biological Vaccines Product Offered
13.8.3 DHN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 DHN Main Business Overview
13.8.5 DHN Latest Developments
13.9 WINSUN
13.9.1 WINSUN Company Information
13.9.2 WINSUN Veterinary Biological Vaccines Product Offered
13.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 WINSUN Main Business Overview
13.9.5 WINSUN Latest Developments
13.10 Elanco
13.10.1 Elanco Company Information
13.10.2 Elanco Veterinary Biological Vaccines Product Offered
13.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Elanco Main Business Overview
13.10.5 Elanco Latest Developments
13.11 Virbac
13.11.1 Virbac Company Information
13.11.2 Virbac Veterinary Biological Vaccines Product Offered
13.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Virbac Main Business Overview
13.11.5 Virbac Latest Developments
13.12 CAVAC
13.12.1 CAVAC Company Information
13.12.2 CAVAC Veterinary Biological Vaccines Product Offered
13.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CAVAC Main Business Overview
13.12.5 CAVAC Latest Developments
13.13 Kyoto Biken Laboratories
13.13.1 Kyoto Biken Laboratories Company Information
13.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Offered
13.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Kyoto Biken Laboratories Main Business Overview
13.13.5 Kyoto Biken Laboratories Latest Developments
13.14 FATRO
13.14.1 FATRO Company Information
13.14.2 FATRO Veterinary Biological Vaccines Product Offered
13.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 FATRO Main Business Overview
13.14.5 FATRO Latest Developments
13.15 Vaksindo
13.15.1 Vaksindo Company Information
13.15.2 Vaksindo Veterinary Biological Vaccines Product Offered
13.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Vaksindo Main Business Overview
13.15.5 Vaksindo Latest Developments
13.16 Bio-Labs
13.16.1 Bio-Labs Company Information
13.16.2 Bio-Labs Veterinary Biological Vaccines Product Offered
13.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Bio-Labs Main Business Overview
13.16.5 Bio-Labs Latest Developments
13.17 Avimex Animal Health
13.17.1 Avimex Animal Health Company Information
13.17.2 Avimex Animal Health Veterinary Biological Vaccines Product Offered
13.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Avimex Animal Health Main Business Overview
13.17.5 Avimex Animal Health Latest Developments
13.18 MEVAC
13.18.1 MEVAC Company Information
13.18.2 MEVAC Veterinary Biological Vaccines Product Offered
13.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 MEVAC Main Business Overview
13.18.5 MEVAC Latest Developments
13.19 Biovac
13.19.1 Biovac Company Information
13.19.2 Biovac Veterinary Biological Vaccines Product Offered
13.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Biovac Main Business Overview
13.19.5 Biovac Latest Developments
13.20 Atafen
13.20.1 Atafen Company Information
13.20.2 Atafen Veterinary Biological Vaccines Product Offered
13.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Atafen Main Business Overview
13.20.5 Atafen Latest Developments
13.21 Dyntec
13.21.1 Dyntec Company Information
13.21.2 Dyntec Veterinary Biological Vaccines Product Offered
13.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Dyntec Main Business Overview
13.21.5 Dyntec Latest Developments
13.22 Ringpu Biology
13.22.1 Ringpu Biology Company Information
13.22.2 Ringpu Biology Veterinary Biological Vaccines Product Offered
13.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Ringpu Biology Main Business Overview
13.22.5 Ringpu Biology Latest Developments
13.23 Jinyu Bio-technology
13.23.1 Jinyu Bio-technology Company Information
13.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Product Offered
13.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Jinyu Bio-technology Main Business Overview
13.23.5 Jinyu Bio-technology Latest Developments
13.24 Jinhe Biotechnology
13.24.1 Jinhe Biotechnology Company Information
13.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Product Offered
13.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Jinhe Biotechnology Main Business Overview
13.24.5 Jinhe Biotechnology Latest Developments
13.25 China Animal Husbandry Industry
13.25.1 China Animal Husbandry Industry Company Information
13.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Product Offered
13.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 China Animal Husbandry Industry Main Business Overview
13.25.5 China Animal Husbandry Industry Latest Developments
13.26 Wuhan Keqian Biology
13.26.1 Wuhan Keqian Biology Company Information
13.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Product Offered
13.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Wuhan Keqian Biology Main Business Overview
13.26.5 Wuhan Keqian Biology Latest Developments
13.27 Pulike Biological Engineering
13.27.1 Pulike Biological Engineering Company Information
13.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Product Offered
13.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Pulike Biological Engineering Main Business Overview
13.27.5 Pulike Biological Engineering Latest Developments
13.28 Chengdu Kanghua Biological Products
13.28.1 Chengdu Kanghua Biological Products Company Information
13.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Offered
13.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 Chengdu Kanghua Biological Products Main Business Overview
13.28.5 Chengdu Kanghua Biological Products Latest Developments
14 Research Findings and Conclusion
Table 1. Veterinary Biological Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Veterinary Biological Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Others
Table 6. Global Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)
Table 7. Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global Veterinary Biological Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global Veterinary Biological Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global Veterinary Biological Vaccines Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)
Table 12. Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global Veterinary Biological Vaccines Revenue by Application (2017-2022)
Table 14. Global Veterinary Biological Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global Veterinary Biological Vaccines Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Veterinary Biological Vaccines Sales by Company (2020-2022) & (K Units)
Table 17. Global Veterinary Biological Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global Veterinary Biological Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Veterinary Biological Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global Veterinary Biological Vaccines Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Veterinary Biological Vaccines Producing Area Distribution and Sales Area
Table 22. Players Veterinary Biological Vaccines Products Offered
Table 23. Veterinary Biological Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Veterinary Biological Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Veterinary Biological Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global Veterinary Biological Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Veterinary Biological Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Veterinary Biological Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global Veterinary Biological Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Veterinary Biological Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
Table 35. Americas Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas Veterinary Biological Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)
Table 39. Americas Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)
Table 41. Americas Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC Veterinary Biological Vaccines Sales by Region (2017-2022) & (K Units)
Table 43. APAC Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC Veterinary Biological Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)
Table 47. APAC Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)
Table 49. APAC Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
Table 51. Europe Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe Veterinary Biological Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. Europe Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. Europe Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Veterinary Biological Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Veterinary Biological Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Veterinary Biological Vaccines
Table 67. Key Market Challenges & Risks of Veterinary Biological Vaccines
Table 68. Key Industry Trends of Veterinary Biological Vaccines
Table 69. Veterinary Biological Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Veterinary Biological Vaccines Distributors List
Table 72. Veterinary Biological Vaccines Customer List
Table 73. Global Veterinary Biological Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Veterinary Biological Vaccines Sales Market Forecast by Region
Table 75. Global Veterinary Biological Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Veterinary Biological Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Veterinary Biological Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Veterinary Biological Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Veterinary Biological Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Veterinary Biological Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Veterinary Biological Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Veterinary Biological Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Veterinary Biological Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Veterinary Biological Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Veterinary Biological Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Veterinary Biological Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Veterinary Biological Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Veterinary Biological Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Veterinary Biological Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. Merck Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Veterinary Biological Vaccines Product Offered
Table 95. Merck Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Zoetis Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Veterinary Biological Vaccines Product Offered
Table 100. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. Boehringer Ingelheim Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Boehringer Ingelheim Veterinary Biological Vaccines Product Offered
Table 105. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Boehringer Ingelheim Main Business
Table 107. Boehringer Ingelheim Latest Developments
Table 108. Ceva Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Ceva Veterinary Biological Vaccines Product Offered
Table 110. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Ceva Main Business
Table 112. Ceva Latest Developments
Table 113. CAHIC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. CAHIC Veterinary Biological Vaccines Product Offered
Table 115. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. CAHIC Main Business
Table 117. CAHIC Latest Developments
Table 118. HVRI Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. HVRI Veterinary Biological Vaccines Product Offered
Table 120. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. HVRI Main Business
Table 122. HVRI Latest Developments
Table 123. Yebio Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Yebio Veterinary Biological Vaccines Product Offered
Table 125. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Yebio Main Business
Table 127. Yebio Latest Developments
Table 128. DHN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. DHN Veterinary Biological Vaccines Product Offered
Table 130. DHN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. DHN Main Business
Table 132. DHN Latest Developments
Table 133. WINSUN Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. WINSUN Veterinary Biological Vaccines Product Offered
Table 135. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. WINSUN Main Business
Table 137. WINSUN Latest Developments
Table 138. Elanco Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Elanco Veterinary Biological Vaccines Product Offered
Table 140. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Elanco Main Business
Table 142. Elanco Latest Developments
Table 143. Virbac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Virbac Veterinary Biological Vaccines Product Offered
Table 145. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Virbac Main Business
Table 147. Virbac Latest Developments
Table 148. CAVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. CAVAC Veterinary Biological Vaccines Product Offered
Table 150. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. CAVAC Main Business
Table 152. CAVAC Latest Developments
Table 153. Kyoto Biken Laboratories Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Kyoto Biken Laboratories Veterinary Biological Vaccines Product Offered
Table 155. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Kyoto Biken Laboratories Main Business
Table 157. Kyoto Biken Laboratories Latest Developments
Table 158. FATRO Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. FATRO Veterinary Biological Vaccines Product Offered
Table 160. FATRO Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. FATRO Main Business
Table 162. FATRO Latest Developments
Table 163. Vaksindo Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Vaksindo Veterinary Biological Vaccines Product Offered
Table 165. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Vaksindo Main Business
Table 167. Vaksindo Latest Developments
Table 168. Bio-Labs Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Bio-Labs Veterinary Biological Vaccines Product Offered
Table 170. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Bio-Labs Main Business
Table 172. Bio-Labs Latest Developments
Table 173. Avimex Animal Health Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Avimex Animal Health Veterinary Biological Vaccines Product Offered
Table 175. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Avimex Animal Health Main Business
Table 177. Avimex Animal Health Latest Developments
Table 178. MEVAC Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. MEVAC Veterinary Biological Vaccines Product Offered
Table 180. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 181. MEVAC Main Business
Table 182. MEVAC Latest Developments
Table 183. Biovac Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Biovac Veterinary Biological Vaccines Product Offered
Table 185. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 186. Biovac Main Business
Table 187. Biovac Latest Developments
Table 188. Atafen Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Atafen Veterinary Biological Vaccines Product Offered
Table 190. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 191. Atafen Main Business
Table 192. Atafen Latest Developments
Table 193. Dyntec Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 194. Dyntec Veterinary Biological Vaccines Product Offered
Table 195. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 196. Dyntec Main Business
Table 197. Dyntec Latest Developments
Table 198. Ringpu Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 199. Ringpu Biology Veterinary Biological Vaccines Product Offered
Table 200. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 201. Ringpu Biology Main Business
Table 202. Ringpu Biology Latest Developments
Table 203. Jinyu Bio-technology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 204. Jinyu Bio-technology Veterinary Biological Vaccines Product Offered
Table 205. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 206. Jinyu Bio-technology Main Business
Table 207. Jinyu Bio-technology Latest Developments
Table 208. Jinhe Biotechnology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 209. Jinhe Biotechnology Veterinary Biological Vaccines Product Offered
Table 210. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 211. Jinhe Biotechnology Main Business
Table 212. Jinhe Biotechnology Latest Developments
Table 213. China Animal Husbandry Industry Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 214. China Animal Husbandry Industry Veterinary Biological Vaccines Product Offered
Table 215. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 216. China Animal Husbandry Industry Main Business
Table 217. China Animal Husbandry Industry Latest Developments
Table 218. Wuhan Keqian Biology Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 219. Wuhan Keqian Biology Veterinary Biological Vaccines Product Offered
Table 220. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 221. Wuhan Keqian Biology Main Business
Table 222. Wuhan Keqian Biology Latest Developments
Table 223. Pulike Biological Engineering Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 224. Pulike Biological Engineering Veterinary Biological Vaccines Product Offered
Table 225. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 226. Pulike Biological Engineering Main Business
Table 227. Pulike Biological Engineering Latest Developments
Table 228. Chengdu Kanghua Biological Products Basic Information, Veterinary Biological Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 229. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Offered
Table 230. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 231. Chengdu Kanghua Biological Products Main Business
Table 232. Chengdu Kanghua Biological Products Latest Developments
List of Figures
Figure 1. Picture of Veterinary Biological Vaccines
Figure 2. Veterinary Biological Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Biological Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Veterinary Biological Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Veterinary Biological Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Live Attenuated Vaccines
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Product Picture of Others
Figure 12. Global Veterinary Biological Vaccines Sales Market Share by Type in 2021
Figure 13. Global Veterinary Biological Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. Veterinary Biological Vaccines Consumed in Livestock
Figure 15. Global Veterinary Biological Vaccines Market: Livestock (2017-2022) & (K Units)
Figure 16. Veterinary Biological Vaccines Consumed in Swine
Figure 17. Global Veterinary Biological Vaccines Market: Swine (2017-2022) & (K Units)
Figure 18. Veterinary Biological Vaccines Consumed in Chicken
Figure 19. Global Veterinary Biological Vaccines Market: Chicken (2017-2022) & (K Units)
Figure 20. Veterinary Biological Vaccines Consumed in Others
Figure 21. Global Veterinary Biological Vaccines Market: Others (2017-2022) & (K Units)
Figure 22. Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
Figure 23. Global Veterinary Biological Vaccines Revenue Market Share by Application in 2021
Figure 24. Veterinary Biological Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Veterinary Biological Vaccines Revenue Market Share by Company in 2021
Figure 26. Global Veterinary Biological Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Veterinary Biological Vaccines Revenue Market Share by Geographic Region in 2021
Figure 28. Global Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
Figure 29. Global Veterinary Biological Vaccines Revenue Market Share by Country/Region in 2021
Figure 30. Americas Veterinary Biological Vaccines Sales 2017-2022 (K Units)
Figure 31. Americas Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. APAC Veterinary Biological Vaccines Sales 2017-2022 (K Units)
Figure 33. APAC Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Europe Veterinary Biological Vaccines Sales 2017-2022 (K Units)
Figure 35. Europe Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Veterinary Biological Vaccines Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Veterinary Biological Vaccines Revenue 2017-2022 ($ Millions)
Figure 38. Americas Veterinary Biological Vaccines Sales Market Share by Country in 2021
Figure 39. Americas Veterinary Biological Vaccines Revenue Market Share by Country in 2021
Figure 40. United States Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Veterinary Biological Vaccines Sales Market Share by Region in 2021
Figure 45. APAC Veterinary Biological Vaccines Revenue Market Share by Regions in 2021
Figure 46. China Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Veterinary Biological Vaccines Sales Market Share by Country in 2021
Figure 53. Europe Veterinary Biological Vaccines Revenue Market Share by Country in 2021
Figure 54. Germany Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Veterinary Biological Vaccines Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Veterinary Biological Vaccines Revenue Market Share by Country in 2021
Figure 61. Egypt Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Veterinary Biological Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Veterinary Biological Vaccines in 2021
Figure 67. Manufacturing Process Analysis of Veterinary Biological Vaccines
Figure 68. Industry Chain Structure of Veterinary Biological Vaccines
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...